Skip to main content
FinSpry Logo
FinSpry
P
PLYX
(NASDAQ)
Polaryx Therapeutics, Inc.
$7.14-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Polaryx Therapeutics (PLYX) Stock Price & Financial Analysis

Polaryx Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.79 - $7.60
52-Week High$48.91
52-Week Low$2.20
Open$7.45
Volume251.30K
Average Volume (3M)251.30K
Market Cap1.35B
Shares Outstanding189.37M
Price to Book (P/B)271.50
EV/EBITDA-187.80
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Polaryx Therapeutics

What is the current stock price for PLYX?

As of the latest trading session, PLYX stock trades at $7.14. The 52-week range is $2.20–$48.91, with a day range of $6.79–$7.60.

What is the P/E ratio for PLYX?

The P/E ratio (Price-to-Earnings) for PLYX is shown in the Key Statistics section. This valuation metric helps compare Polaryx Therapeutics, Inc. to industry peers.

Does PLYX pay dividends?

Polaryx Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PLYX?

Based on 1 analyst, the consensus for PLYX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PLYX?

Polaryx Therapeutics's market capitalization is $1.35B, classifying it as a small-cap company. Polaryx Therapeutics operates in the Healthcare sector within the Biotechnology industry.